Bioderma - 'Photoderm M SPF50+' Tinted Sunscreen - Claire 40 ml| Skin Type | Depigmented skin |
|---|
Product benefits
- 66% BLUE LIGHT PROTECTION: Prevents melasma recurrence
- SUN ACTIVE DEFENSE: high-technology sun protection, reinforced against UVAs
- Clarifies existing dark spots thanks to glabridin
- Unifies: High concentration of pigments, high coverage without mask effect
- 8H mattifying and matte finish
Suitable for pregnant and breastfeeding women - Gel-cream texture - Non-sticky- Non-greasy - Unfragranced - Very good cutaneous and ocular tolerance - Non-comedogenic - Water, heat and high humidity resistant
*Clinical study made amongst tinted sunscreens with very high protection targeting hyperpigmentation, on 20 volunteers aged 18 to 50 years with sensitive skin for 5 days.
All BIODERMA products are formulated according to the ecobiology principles, which is at the heart of NAOS approach to respect the skin's ecosystem and preserve its health in a lasting way.
UVB & UVA are the primary triggering factors of hyperpigmentation. It has also been recently proven that the major element triggering melasma is visible light and particularly a part of it, blue light.
Photoderm M SPF50+ was tailored with dermatologists to address the causes and consequences of melasma:
- It provides the highest blue light protection on the market: 61%* to prevent recurrences.
- Enriched with glabridin, the new patented formula also biologically regulates the pigmentation process and thus helps to prevent pigmentation spots, reduce their appearance and limit their recurrence.
- The high concentration of pigments have the power to stop blue light damages. It also allows high coverage to perfectly hide dark spots with a pleasant powdery finish and mattifying power.
- The SUN ACTIVE DEFENSE technology, rather than overlaoding the skin with filters, reinforces the skin's self-defence abilities to compensate for the biological impacts of UVA. It brings an antioxidant protection and maintains skin immune defenses under the sun.
A real dermatological sun care product, this gel-cream combines high technology and sensory appeal to promote its daily application, to increase the chances of success in preventing the pathology and its recurrence.
How to use it
Apply daily to minimize the risks of pigmentation.
Step 1: Apply evenly and generously daily to face and neck before sun exposure (a small amount of product lowers the level of sun protection).
Step 2: Reapply after sweating, swimming or towel drying to maintain protection.
Avoid contacts with fabrics. Adults. Apply to healthy skin. In case of contact with eyes, rinse immediately with abundant water. Over exposure to the sun can damage the health even with sun protection.
ECOBIOLOGY, OUR UNIQUE APPROACH TO PRESERVE SKIN HEALTH LASTINGLY
True to NAOS vision, ecobiology reproduces the skin’s natural processes to help it strengthen itself and adapt to its environment. It keeps the skin naturally strong, beautiful and healthy, in a sustainable way.
FRENCH INDEPENDENT LABORATORIES
Designing all our products in house, in NAOS laboratories in the heart of Provence. Made in France.
A better understanding for better care
UV exposure appears to be the primary factor in the development and recurrence of melasma, and it has been discovered more recently that visible light, especially blue light, affects pigmentation, making melasma conditions worse.
Skin must be protected against not only UVB and UVA, but especially against blue light to avoid melasma and control its relapses. Tinted formulas protect better against visible light because the pigments present in the formula are have the power to stop blue light damage.
Results proven by clinical studies
Immediate results
High coverage
Perfectly covers hyperpigmentation marks for 98% of the users (2)
Mattifies
Mattifies throughout the day for 97% of the users (2)
No mask effect
Unifies without leaving a mask-effect for 88% of the users (2)
Lasting results
Prevents melasma
Prevents melasma from worsening for 96% of the users (2)
Corrects melasma
Diminution of modified Melasma Area Severity Index (mMASI) by almost 1/3 (3)
Clarifies the skin for 90% of the users (2)
(1) Clinical study made amongst tinted sunscreens with very high protection targeting hyperpigmentation, on 20 volunteers aged 18 to 50 years with sensitive skin for 5 days.
(2) Usage test on 106 volunteers aged 25 to 45 years with 100% sensitive skin, normal, combination or oily skin, for 14 days.
(3) Clinical study to evaluate the efficacy to prevent worsening of melasma on 68 volunteers aged 25 to 45 with 100% sensitive skin, normal, combination or oily skin, for 140 days.
